Head/Neck Cancer Pancreatic Cancer Unigef 250 - 30 Tablets $25.30 ~ No reviews yet Unigef 250 is a generic formulation of gefitinib 250mg, a first-generation oral tyrosine kinase in... Unigef 250 is a generic formulation of gefitinib 250mg, a first-generation oral tyrosine kinase inhibitor (TKI) developed to selectively inhibit epidermal growth factor receptor (EGFR) activity in advanced non-small cell lung cancer (NSCLC). By blocking EGFR-driven signaling pathways, it disrupts tumor cell proliferation and survival, making it a well-established first-line therapy for patients with EGFR mutation-positive lung adenocarcinoma. Its oral formulation provides a convenient targeted treatment option, particularly valuable in personalized oncology approaches. Show more